Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry

Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

(2014) Ariane Wohlfarth et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites

(2014) Sabina Strano-Rossi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC andα-PVT, by human liver microsome

(2014) Takahiro Takayama et al.   BIOMEDICAL CHROMATOGRAPHY

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

(2014) Marisol S. Castaneto et al.   DRUG AND ALCOHOL DEPENDENCE

High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liv

(2014) Adarsh S. Gandhi et al.   Drug Testing and Analysis

Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry

(2014) Niels Bjerre Holm et al.   Drug Testing and Analysis

Determination of major metabolites of MAM-2201 and JWH-122 in in vitro and in vivo studies to distinguish their intake

(2014) Moonhee Jang et al.   FORENSIC SCIENCE INTERNATIONAL

Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS

(2014) Ariane Wohlfarth et al.   Bioanalysis

First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

(2013) Adarsh S. Gandhi et al.   AAPS Journal

First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry

(2013) A. Wohlfarth et al.   CLINICAL CHEMISTRY

In vivoandin vitrometabolism of the synthetic cannabinoid JWH-200

(2013) Nik De Brabanter et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids

(2012) Tim Sobolevsky et al.   Drug Testing and Analysis

New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products

(2012) Nahoko Uchiyama et al.   Forensic Toxicology

Characterization ofIn VitroMetabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC-MS/MS

(2012) Ming J. Jin et al.   JOURNAL OF FORENSIC SCIENCES

Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques

(2012) M. Hutter et al.   JOURNAL OF MASS SPECTROMETRY

Gas and liquid chromatography–mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures

(2011) Andrej Grigoryev et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

(2011) Lisa K. Brents et al.   PLoS One

In vitro phase I metabolism of the synthetic cannabimimetic JWH-018

(2010) Annette Wintermeyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Acyl glucuronides: the good, the bad and the ugly

(2010) Sophie L. Regan et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion

(2008) Colleen A. McNaney et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES